Innovative Product Launches Biosense Webster Inc. has recently launched cutting-edge products like the ELIOSTAR Balloon Ablation Catheter and the CARTO 3 electro-anatomical mapping system, showcasing a commitment to innovation and technological advancement in the field of cardiac arrhythmia treatment.
Global Market Expansion With successful launches in Europe, Biosense Webster Inc. is actively expanding its presence and market reach beyond the U.S. This international expansion provides an opportunity for sales development representatives to tap into new markets and establish partnerships in regions where the company is gaining traction.
CE Mark Approvals The recent European CE mark approval of the VARIPULSE Platform underscores Biosense Webster's compliance with regulatory standards and opens doors for sales representatives to target healthcare facilities and clinicians in Europe for the adoption of advanced cardiac arrhythmia treatment technologies.
Strategic Collaborations Collaborative efforts with industry leaders like Boston Scientific indicate that Biosense Webster is part of a network that is collectively advancing the field of cardiac arrhythmia treatment. Sales development representatives can leverage these partnerships to explore co-marketing opportunities and extend the company's sales outreach.
Research & Development Investment Being involved in the development of Pulsed Field Ablation (PFA) systems and conducting pivotal studies like the SmartPulse study demonstrate Biosense Webster's dedication to R&D. This focus on innovation presents a chance for sales professionals to align with upcoming breakthrough technologies and cater to evolving market needs.
10K
$1B
57K$1B
5K$1B
103K$1B
93K$1B
43K$1B
46K$1B
13K$1BBiosense Webster uses 8 technology products and services including MATLAB, Google Analytics, Microsoft Excel, and more. Explore Biosense Webster's tech stack below.
| Biosense Webster Email Formats | Percentage |
| FLast@its.jnj.com | 62% |
| LFirst@its.jnj.com | 6% |
| First.Last@its.jnj.com | 5% |
| F-Last@its.jnj.com | 3% |
| FirstLast@its.jnj.com | 2% |
| FiLast@its.jnj.com | 1% |
| LastFir@its.jnj.com | 2% |
| First_Last@its.jnj.com | 1% |
| LastFirst@its.jnj.com | 1% |
| First-Last@its.jnj.com | 2% |
| Last.First@its.jnj.com | 1% |
| FirLast@its.jnj.com | 1% |
| Last_First@its.jnj.com | 2% |
| LastF@its.jnj.com | 1% |
| LastFi@its.jnj.com | 1% |
| FirstL@its.jnj.com | 1% |
| Last.F@its.jnj.com | 1% |
| F_Last@its.jnj.com | 1% |
| FirstLas@its.jnj.com | 1% |
| FMLast@its.jnj.com | 1% |
| FMiddleLast@its.jnj.com | 1% |
| FL@its.jnj.com | 1% |
| FirstMiddleLas@its.jnj.com | 1% |
| LF@its.jnj.com | 1% |
| FLast@bwius.jnj.com | 72% |
| Last@bwius.jnj.com | 25% |
| First.Last@bwius.jnj.com | 2% |
| First_Last@bwius.jnj.com | 1% |
| First.Last@biosensewebster.com | 64% |
| FLast@biosensewebster.com | 23% |
| FirstLast@biosensewebster.com | 8% |
| LastF@biosensewebster.com | 5% |
Medical Equipment ManufacturingCalifornia, United States1001-5000 Employees
Biosense Webster, Inc., part of Johnson and Johnson Medtech, is the global leader in the science, diagnosis and treatment of heart rhythm disorders. We partner with clinicians to develop innovative technologies that improve the quality of care for arrhythmia patients worldwide. More information can be found at https://bit.ly/47DdIPR.
Company Overview
Media & News
Funding & FinancialsBiosense Webster's revenue is in the range of $100M$1B
Funding & FinancialsBiosense Webster's revenue is in the range of $100M$1B
1-888-653-2347 
support@leadiq.com